{"id":236079,"date":"2026-04-28T14:45:49","date_gmt":"2026-04-28T19:45:49","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/04\/we-may-finally-have-a-cure-for-many-different-autoimmune-conditions"},"modified":"2026-04-28T14:45:49","modified_gmt":"2026-04-28T19:45:49","slug":"we-may-finally-have-a-cure-for-many-different-autoimmune-conditions","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/04\/we-may-finally-have-a-cure-for-many-different-autoimmune-conditions","title":{"rendered":"We may finally have a cure for many different autoimmune conditions"},"content":{"rendered":"

<\/a><\/p>\n

Our immune systems never stop targeting cells they regard as a threat, so it\u2019s really bad news when rogue immune cells mistakenly turn on us, as they do in autoimmune conditions. Existing treatments suppress these attacks, but don\u2019t stop them. But a new approach that addresses the cause of these disorders by killing off the rogue cells is proving wildly successful.<\/p>\n

\u201cAll the big pharma companies are jumping on the bandwagon now,\u201d says Reuben Benjamin at King\u2019s College London. There are dozens of clinical trials under way around the world, and the first treatments could be approved as early as next year, he says, as they\u2019re proving to be vastly superior to those currently used.<\/p>\n

The key to these new treatments are genetically engineered cells known as CAR T-cells. These are made from the T-cells that your immune system usually employs to kill off invasive bacteria or virus-infected cells. The T-cells are extracted from a person, programmed to attack a specific kind of cell and then returned to that individual.<\/p>\n

Image: Location South\/Alamy<\/p>\n

\n

A revolutionary cancer treatment is now being applied to a wide range of autoimmune disorders. Columnist Michael Le Page<\/strong> finds it is proving to be even more effective than expected.<\/p>\n

By Michael Le Page<\/a><\/p>\n

Continue reading \u201cWe may finally have a cure for many different autoimmune conditions\u201d | ><\/a><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"

Our immune systems never stop targeting cells they regard as a threat, so it\u2019s really bad news when rogue immune cells mistakenly turn on us, as they do in autoimmune conditions. Existing treatments suppress these attacks, but don\u2019t stop them. But a new approach that addresses the cause of these disorders by killing off the [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412],"tags":[],"class_list":["post-236079","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/236079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=236079"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/236079\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=236079"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=236079"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=236079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}